BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35227787)

  • 1. Novel circular RNA circ_0086722 drives tumor progression by regulating the miR-339-5p/STAT5A axis in prostate cancer.
    Deng W; Zhou X; Zhu K; Chen R; Liu X; Chen L; Jiang H; Hu B; Zeng Z; Cheng X; Yao Z; Nie J; Xiong S; Zhang C; Guo J; Fu B; Wang G
    Cancer Lett; 2022 May; 533():215606. PubMed ID: 35227787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hsa_circ_0005221 promotes prostate cancer progression through the miR-339-5p/STAT5a pathway].
    Chen SS; Zhang YW; Wang YL; Gao Y; Wang C; Hu Q; Wu TG; Tao SC; Zhao JX; Chen M
    Zhonghua Nan Ke Xue; 2021 Apr; 27(4):301-308. PubMed ID: 34914211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Circular RNA Circ_0085494 Regulates Prostate Cancer Progression Through NRBP1/miR-497-5p Axis.
    Cao C; Sun G; Le K; Xu Q; Liu C
    Biochem Genet; 2023 Oct; 61(5):1775-1790. PubMed ID: 36790665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p.
    Yu YZ; Lv DJ; Wang C; Song XL; Xie T; Wang T; Li ZM; Guo JD; Fu DJ; Li KJ; Wu DL; Chan FL; Feng NH; Chen ZS; Zhao SC
    Mol Cancer; 2022 Jan; 21(1):12. PubMed ID: 34986849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0076305 facilitates prostate cancer development via sponging miR-411-5p and regulating PGK1.
    Ding X; Sun J; Zhang X
    Andrologia; 2022 Jul; 54(6):e14406. PubMed ID: 35238066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsa_circ_0063329 inhibits prostate cancer growth and metastasis by modulating the miR-605-5p/tgif2 axis.
    Lv D; Cen S; Yang S; Zou Z; Zhong J; Pan Z; Deng N; Li Y; Wu K; Wang J; Liu P
    Cell Cycle; 2023 May; 22(9):1101-1115. PubMed ID: 36740902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hsa_circ_0062019 promotes the proliferation, migration, and invasion of prostate cancer cells via the miR-195-5p/HMGA2 axis.
    Wang P; Zhang L; Yin S; Xu Y; Tai S; Zhang LI; Liang C
    Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(7):815-822. PubMed ID: 33978716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation.
    Chen LY; Wang L; Ren YX; Pang Z; Liu Y; Sun XD; Tu J; Zhi Z; Qin Y; Sun LN; Li JM
    Mol Cancer; 2020 Nov; 19(1):164. PubMed ID: 33225938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA 0007255 regulates the progression of breast cancer through miR-335-5p/SIX2 axis.
    Jia Q; Ye L; Xu S; Xiao H; Xu S; Shi Z; Li J; Chen Z
    Thorac Cancer; 2020 Mar; 11(3):619-630. PubMed ID: 31962380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA circ_0001588 sponges miR-211-5p to facilitate the progression of glioblastoma via up-regulating YY1 expression.
    Wang Q; Zheng D; Li Y; Zhang Y; Sui R; Chen Y; Liang H; Shi J; Pan R; Xu X; Sun D
    J Gene Med; 2021 Oct; 23(10):e3371. PubMed ID: 34105224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA hsa_circ_0000730 restrains cell proliferation, migration, and invasion in cervical cancer through miR-942-5p/PTEN axis.
    Yuan DD; Jia CD; Yan MY; Wang J
    Kaohsiung J Med Sci; 2021 Nov; 37(11):964-972. PubMed ID: 34562344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Expression of Several Circular RNAs and Knockdown of hsa_circ_0005556 Exerts Oncogenic Functions by miR-767-5p in Gastric Cancer.
    Geng H; Li K; Pan Q; Tao S; Li C; Zhao H; Zhao X
    Med Sci Monit; 2020 Jul; 26():e921163. PubMed ID: 32728015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA-ABCB10 suppresses hepatocellular carcinoma progression through upregulating NRP1/ABL2 via sponging miR-340-5p/miR-452-5p.
    Yang W; Ju HY; Tian XF
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2347-2357. PubMed ID: 32196586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0001686 Promotes Prostate Cancer Progression by Up-Regulating SMAD3/TGFBR2
    Pan J; Liu Z; Yang Z; Liang E; Fang C; Zhang D; Zhou X; Niu Y; Xin Z; Chen Y; Cai Q
    World J Mens Health; 2022 Jan; 40(1):149-161. PubMed ID: 34169675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircRNA pappalysin 1 facilitates prostate cancer development through miR-515-5p/FKBP1A axis.
    Wang G; Zhao H; Duan X; Ren Z
    Andrologia; 2021 Dec; 53(11):e14227. PubMed ID: 34469009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615-5p/fibronectin 1 pathway.
    Du J; Zhang G; Qiu H; Yu H; Yuan W
    Cell Mol Biol Lett; 2019; 24():72. PubMed ID: 31889960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis.
    Zhang H; Li M; Zhang J; Shen Y; Gui Q
    Drug Des Devel Ther; 2021; 15():1835-1849. PubMed ID: 33976535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circ_0008360 Inhibits the Proliferation, Migration, and Inflammation and Promotes Apoptosis of Fibroblast-Like Synoviocytes by Regulating miR-135b-5p/HDAC4 Axis in Rheumatoid Arthritis.
    Hao J; Chen Y; Yu Y
    Inflammation; 2022 Feb; 45(1):196-211. PubMed ID: 34462830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circ_0048764 promotes the development of breast cancer by regulating microRNA-1296-5p/tripartite motif containing 14 axis.
    Xie F; Xiong Y; Yan J; Wang L; Yan W
    Bioengineered; 2022 Feb; 13(2):1963-1974. PubMed ID: 34787066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.